Actively Recruiting
Assessment of Usability and Preliminary Effectiveness of a Digital Sleep Aid in an Italian Sample
Led by Universita di Verona · Updated on 2025-04-17
50
Participants Needed
1
Research Sites
52 weeks
Total Duration
On this page
Sponsors
U
Universita di Verona
Lead Sponsor
S
Santer Reply S.p.A. Milan, Italy
Collaborating Sponsor
AI-Summary
What this Trial Is About
Chronic insomnia affects approximately 30% of the Italian population, leading to significant impairments in daily functioning and overall health. While Cognitive Behavioral Therapy for Insomnia (CBT-I) is the recommended first-line treatment, access is limited due to a shortage of trained specialists and resources within the Italian healthcare system. This study aims to evaluate the usability, acceptability, and preliminary effectiveness of a mobile application designed to assist individuals with chronic insomnia. The app offers digital sleep diaries, personalized sleep hygiene education, relaxation exercises, and an interactive chatbot to promote healthy sleep behaviors. Fifty adult participants diagnosed with chronic insomnia will be randomly assigned to either the intervention group, which will use the mobile application alongside their usual treatment, or to a control group receiving only standard care. The primary outcomes will assess the app's usability and participants' adherence to sleep hygiene practices. Secondary outcomes will evaluate changes in insomnia severity, mood, and quality of life. Assessments will occur at the start of the study, after the 8-week intervention, and at a 6-month follow-up to explore the intervention's long-term effects.
CONDITIONS
Official Title
Assessment of Usability and Preliminary Effectiveness of a Digital Sleep Aid in an Italian Sample
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults aged 18 to 70 years
- Diagnosis of chronic insomnia according to DSM-5 criteria
- Willingness to participate in the study and provide informed consent
- Personal active email address
- Ownership of a compatible mobile device with internet access (for the DHT group)
You will not qualify if you...
- Medical conditions requiring hospital admission during the study period
- Comorbid diagnosis of sleep-related breathing disorders
- Neurological disorders affecting sleep such as narcolepsy, parasomnias, epilepsy, or neurodegenerative diseases
- Currently receiving psychological treatment for insomnia or planning to do so within the next 6 months
- Incompatible smartphone or lack of internet access (for DHT group)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Ospedale Borgo Roma - Neurologia B
Verona, Verona, Italy, 37129
Actively Recruiting
Research Team
E
Elena Antelmi, Professor - Neurology
CONTACT
G
Giacomo Carollo, MSc - Psychology
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here